Meihua International Medical Technologies Faces Nasdaq Delisting Risk
Ticker: MHUAF · Form: 6-K · Filed: Dec 5, 2024 · CIK: 1835615
| Field | Detail |
|---|---|
| Company | Meihua International Medical Technologies Co., Ltd. (MHUAF) |
| Form Type | 6-K |
| Filed Date | Dec 5, 2024 |
| Risk Level | high |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $1, $1.00, $5,000 |
| Sentiment | bearish |
Sentiment: bearish
Topics: listing-compliance, delisting-risk, nasdaq
Related Tickers: MHUA
TL;DR
Meihua Intl Medical Tech (MHUA) is at risk of getting booted from Nasdaq due to low stock price.
AI Summary
On December 3, 2024, Meihua International Medical Technologies Co., Ltd. received a notification from the Nasdaq Stock Market, LLC stating that the Company is no longer in compliance with the minimum bid price requirements. This means the Company's stock price has fallen below the $1.00 threshold required to remain listed on Nasdaq.
Why It Matters
Failure to regain compliance with Nasdaq's minimum bid price rule could lead to the delisting of Meihua International Medical Technologies' shares, impacting liquidity and investor confidence.
Risk Assessment
Risk Level: high — The company has received a notification from Nasdaq for non-compliance with the minimum bid price requirement, indicating a significant risk of delisting.
Key Numbers
- $1.00 — Minimum Bid Price (The threshold the company's stock price has fallen below, leading to non-compliance with Nasdaq listing rules.)
Key Players & Entities
- Meihua International Medical Technologies Co., Ltd. (company) — The company that received the notification
- Nasdaq Stock Market, LLC (company) — The exchange that issued the non-compliance notification
- December 3, 2024 (date) — Date the notification was received
FAQ
What specific rule has Meihua International Medical Technologies violated according to the Nasdaq notification?
The company is no longer in compliance with the minimum bid price requirements set by the Nasdaq Stock Market, LLC.
When did Meihua International Medical Technologies receive this notification from Nasdaq?
The Company received the notification on December 3, 2024.
What is the consequence of not meeting the minimum bid price requirement on Nasdaq?
Failure to meet the minimum bid price requirement can lead to the delisting of the company's securities from the Nasdaq Stock Market.
What is the principal executive office address of Meihua International Medical Technologies?
The principal executive office is located at 88 Tongda Road, Touqiao Town, Guangling District, Yangzhou, 225000, People's Republic of China.
Does Meihua International Medical Technologies file annual reports under Form 20-F or Form 40-F?
The Company files annual reports under cover of Form 20-F.
Filing Stats: 575 words · 2 min read · ~2 pages · Grade level 16.2 · Accepted 2024-12-05 16:10:03
Key Financial Figures
- $1 — ties to maintain a minimum bid price of $1 per share and, according to the Notice,
- $1.00 — any’s ordinary shares is at least $1.00 for a minimum of 10 consecutive busines
- $5,000 — mpany would be required to pay Nasdaq a $5,000 application fee to transfer to the Nasd
Filing Documents
- ea0223748-6k_meihua.htm (6-K) — 11KB
- 0001213900-24-106050.txt ( ) — 12KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Meihua International Medical Technologies Co., Ltd. Dated: December 5, 2024 By: /s/ Xin Wang Name: Xin Wang Title: Chief Executive Officer (Principal Executive Officer) 2